Last updated on June 2019

A Study to Evaluate the Efficacy Safety and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)


Brief description of study

The purpose of this study is to evaluate the efficacy, safety, and tolerability of guselkumab in adult participants with moderate to severe hidradenitis suppurativa (HS).

Clinical Study Identifier: NCT03628924

Find a site near you

Start Over

UC Davis School of Medicine

Sacramento, CA United States
  Connect »

Renstar Medical Research

Ocala, FL United States
  Connect »

Park Avenue Dermatology

Orange Park, FL United States
  Connect »

Forward Clinical Trials

Tampa, FL United States
  Connect »

Great Lakes Clinical Trials

Chicago, IL United States
  Connect »

Indiana Clinical Trial Center

Plainfield, IN United States
  Connect »

Tufts Medical Center

Boston, MA United States
  Connect »

Hamzavi Dermatology

Fort Gratiot, MI United States
  Connect »

Central Dermatology

Saint Louis, MO United States
  Connect »

Clinical Studies Group

Henderson, NV United States
  Connect »

Ohio State University

Columbus, OH United States
  Connect »

Clinical Partners, LLC

Johnston, RI United States
  Connect »

Progressive Clinical Research

San Antonio, TX United States
  Connect »

Enverus Medical

Surrey, BC Canada
  Connect »

Bispebjerg Hospital

København Nv, Denmark
  Connect »

CHU Saint-etienne

St Priest En Jarez, France
  Connect »

Radboudumc

Nijmegen, Netherlands
  Connect »

Bispebjerg Hospital

København NV, Denmark
  Connect »

Bispebjerg Hospital

København NV, Denmark
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.